MedTrace Logo

Gastric Cancer Endoscopic Screening in an Intermediate-risk Country - ROGCAS, a Dual-centre Pilot Program

NCT06316882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 349

Last updated 2025-02-27

No results posted yet for this study

Summary

Endoscopic screening of gastric cancer combined with screening colonoscopy

Conditions

  • Gastric Cancer
  • Gastric (Stomach) Cancer
  • Atrophic Gastritis
  • Intestinal Metaplasia of Gastric Mucosa
  • HELICOBACTER PYLORI INFECTIONS
  • High Grade Intraepithelial Neoplasia

Interventions

DIAGNOSTIC_TEST

Screening endoscopy

We perform upper endoscopy, when the patient authorizes it, during their screening colonoscopy

Sponsors & Collaborators

  • NOVA Medical School

    collaborator OTHER

  • Universidade Nova de Lisboa

    collaborator OTHER

  • Unidade Local De Saúde Do Norte Alentejano

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-03
Primary Completion
2025-02-24
Completion
2025-02-24

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06316882 on ClinicalTrials.gov